Article
Individualized treatment of NSCLC: from research to clinical practice.
Neoplasma - 1 Jan 2013
Wang Y, Liu Z D, Zhao L M, Du C X, Xi X M, Mi Y L, Peng Y, Li W G, Cheng F, Zhang X R, Zheng Y Q, Tang K K, Yang H Y, Chu D T
Abstract excerpt
The exact clinical significance of EGFR mutation status in NSCLC at the time of initial diagnosis remains disputable. The gene expression module in NSCLC for chemotherapy outcome prediction needs to be developed. We analyzed 56 patients with NSCLC received chemotherapy either with (n=20) or without EGFR-TKIs (n=36) between 2008 and 2012 in China. EGFR mutation test and gene expression profiling were performed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.